Duration of adjuvant trastuzumab: might less be more?
نویسندگان
چکیده
منابع مشابه
Duration of adjuvant trastuzumab treatment in routine practice.
BACKGROUND Trastuzumab is used for the adjuvant (postoperative) treatment of (HER2)-positive early breast cancer. The duration of treatment is set at one year. The goal of our study was to examine the effective duration of trastuzumab treatment in routine clinical practice. PATIENTS AND METHODS We performed a retrospective review of all patients with early breast cancer, treated with trastuzu...
متن کاملMacromolecular crowding in vitro as means of emulating cellular interiors: when less might be more.
Fascinating evidence was presented recently that monocrowding with Ficoll 70 (Fc70) improves the refolding speed of VlsE that was unfolded in urea (1). This demonstrated the power of macromolecular crowding as present in cellular interiors. However, we noted that the Fc70 concentrations used in this study (1) are high enough to cause self-crowding (2), meaning compaction of the crowder, thus di...
متن کاملMetronomic Chemotherapy: When Less May Be More
The use of low dose continuous schedules of chemotherapy (i.e. metronomic chemotherapy), delivered at lower doses by necessity compared to traditional dosing schemes, has become an increasingly popular addition to patient management in veterinary medical oncology. While the concept itself is not new, as low dose, maintenance chemotherapy protocols have been important components of treatment for...
متن کاملFluid therapy might be more difficult than you think.
Robert G. Hahn, MD, PhD Young anesthesiologists have long been taught that the replacement of losses is the key target in the management of IV fluid therapy. During surgery, a fluid deficit is undoubtedly created by preoperative fasting, surgical blood loss, evaporation, and urinary excretion. The vasodilatation induced by many forms of anesthesia allows the vascular space to contain more plasm...
متن کاملBelief in optimism might be more problematic than actual optimism
People appear to be biased in their predictions of the future; predicting that projects will take less time than they actually will (see Roy et al., 2005a; Buehler et al., 2010; Halkjelsvik and Jørgensen, 2012, for review) and that they will be unlikely to experience future misfortunes (see Dunning et al., 2004, for review). These biases are frequently attributed to people being overly optimist...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2018
ISSN: 0923-7534
DOI: 10.1093/annonc/mdy480